Form D · Other Technology
CHAMISHI THERAPEUTICS, INC.
Deerfield, IL · CIK 0001790190
Offering snapshot reported Oct 8, 2019 · SEC filing
- Reported sold
- $490K Offering amount: $1.15M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 20, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2019 | Initial | $490,386 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-350542
Total Remaining to be Sold includes issuer's good faith valuation of $288,462 of certain non-cash consideration that may be exchanged for securities in the future.
Series Seed Preferred Stock
Source: Form D, filed Oct 8, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Squinto | Director, Executive |
| James Sullivan | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
711 Dimmeydale Drive
Deerfield, IL, 60015
Deerfield, IL, 60015